About Brinton Pharmaceuticals
Brinton Pharmaceuticals is a company based in Pune (India) founded in 2014 by Rahul Kundanmal Darda. Brinton Pharmaceuticals has raised $16.93 million across 8 funding rounds from investors including BlackSoil, India Alternatives and IDBI trustee. The company has 508 employees as of April 02, 2024. Brinton Pharmaceuticals offers products and services including Therapeutic Solutions. Brinton Pharmaceuticals operates in a competitive market with competitors including LEO Pharma, Incyte, Formation Bio, Arcutis and DermBiont, among others.
- Headquarter Pune, India
- Employees 508 as on 02 Apr, 2024
- Founders Rahul Kundanmal Darda
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Brinton Pharmaceuticals Limited
- Date of Incorporation 27 Sep, 2013
- Jurisdiction Pune, Maharashtra, India
-
Annual Revenue
$18.15 M (USD)0as on Mar 31, 2023
-
Net Profit
-$405.16 K (USD)0as on Mar 31, 2023
-
EBITDA
$26.73 K (USD)0as on Mar 31, 2023
-
Total Equity Funding
$16.93 M (USD)
in 8 rounds
-
Latest Funding Round
$359.54 K (USD), Series B
Apr 30, 2024
-
Investors
BlackSoil
& 10 more
-
Employee Count
508
as on Apr 02, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Brinton Pharmaceuticals
Brinton Pharmaceuticals offers a comprehensive portfolio of products and services, including Therapeutic Solutions.
Products that redefine healing through scientific innovation.
People of Brinton Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Brinton Pharmaceuticals
Brinton Pharmaceuticals has successfully raised a total of $16.93M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $359.54 thousand completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Brinton Pharmaceuticals
Brinton Pharmaceuticals has secured backing from 11 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include BlackSoil, India Alternatives and IDBI trustee.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multiple sectors are targeted for private equity investments.
|
Locked | Locked | Locked | |
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
Private equity fund investing in healthcare and lifesciences in India.
|
Locked | Locked | Locked |
Investor details for Brinton Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Brinton Pharmaceuticals
Investment portfolio details for Brinton Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Brinton Pharmaceuticals
Detailed financials for Brinton Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Brinton Pharmaceuticals Comparisons
Peer comparison for Brinton Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Brinton Pharmaceuticals
Brinton Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LEO Pharma, Incyte, Formation Bio, Arcutis and DermBiont, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drugs for treating dermatology diseases
|
|
| Locked | Locked | Locked |
Small molecules are developed for cancer and skin disease treatments.
|
|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
Immunotherapeutic solutions for dermatological conditions are developed.
|
|
| Locked | Locked | Locked |
Microbial therapeutics for skin diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutic options for chronic inflammatory disorders
|
Detailed competitors of Brinton Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Brinton Pharmaceuticals
Complete news archive for Brinton Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Brinton Pharmaceuticals
Brinton Pharmaceuticals was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Brinton Pharmaceuticals is headquartered in Pune, India. It is registered at Pune, Maharashtra, India.
Brinton Pharmaceuticals is a funded company, having raised a total of $16.93M across 8 funding rounds to date.
As of Apr 02, 2024, the latest employee count at Brinton Pharmaceuticals is 508.
Annual revenue of Brinton Pharmaceuticals is $18.15M as on Mar 31, 2023.
Brinton Pharmaceuticals was founded in 2014 in Pune, India, focusing on the pharmaceutical sector. Formulations are produced for clinical and cosmetic dermatology, respiratory care, gastroenterology, pediatrics, rheumatology, nutraceuticals, and foot care. Research and manufacturing capabilities are integrated to develop treatments addressing skin, gastrointestinal, respiratory, and nutritional health needs. The portfolio includes dermatological treatments, nutritional supplements, and specialized clinical formulations for patient care.
Brinton Pharmaceuticals's top competitors include LEO Pharma, Formation Bio and Arcutis.
Brinton Pharmaceuticals offers Therapeutic Solutions.
Brinton Pharmaceuticals has 11 investors. Key investors include BlackSoil, India Alternatives, IDBI trustee, Tata Capital Healthcare Fund, and Suvarna Jadhav.
The valuation of Brinton Pharmaceuticals is $36.54M as of Apr 2024.